Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma
NCT02981498
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE:
Hepatic arterial infusion chemotherapy
DRUG:
Folfox Protocol
Sponsor
Sun Yat-sen University